Compare ALLT & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLT | ANGO |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 519.6M | 453.0M |
| IPO Year | 2006 | 2004 |
| Metric | ALLT | ANGO |
|---|---|---|
| Price | $6.50 | $10.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.25 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 682.3K | 293.9K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | $14.86 | $9.11 |
| Revenue Next Year | $12.10 | $4.94 |
| P/E Ratio | $469.21 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $4.37 | $8.36 |
| 52 Week High | $11.92 | $13.99 |
| Indicator | ALLT | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 27.87 | 44.31 |
| Support Level | $6.20 | $10.37 |
| Resistance Level | $8.20 | $11.03 |
| Average True Range (ATR) | 0.57 | 0.35 |
| MACD | -0.08 | -0.04 |
| Stochastic Oscillator | 7.07 | 27.64 |
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.